The Latest Cardiac and Vascular News
NEW YORK, Nov. 20, 2025 /PRNewswire/ — Frank J. Veith and Rasit Dinc presented new expert insights on the role of advancing artificial intelligence (AI) technologies in contemporary vascular medicine during a featured session at the 52nd annual VEITH Symposium. Their discussion outlined…
AUDUBON, Pa., Nov. 20, 2025 /PRNewswire/ — AIROS® Medical., Inc., a leading medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous disorders, today announced the release of the AIROS Medical Travel Case. The case will…
AI-driven innovations in digital health and imaging were discussed at the VEITH Symposium, where Frank Veith and Rasit Dinc evaluated the impact of next-generation technologies on vascular treatments NEW YORK, Nov. 19, 2025 /PRNewswire-PRWeb/ — During a special session at the 52nd annual…
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a comprehensive deep clinical AI solution designed to transform the acute assessment and longitudinal management of aortic disease. […]
MONTREAL–(BUSINESS WIRE)–ViTAA Medical Solutions Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for AiORTA™ Plan, the company’s fully automated, hyper-precise aortic surgery planning solution. This clearance represents a key milestone in the evolution of ViTAA’s broader AiORTA™ platform, built to support physicians across the full continuum of […]
DURHAM, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the details of six presentations on the Company’s acellular tissue engineered vessel (ATEV™) that are scheduled for the 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques And Horizons (VEITHsymposium), to be held November 18-22, 2025 in New York, NY. The VEITHsymposium is a premier educational event for vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists.
ST. LOUIS, Nov. 10, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received U.S. Food and Drug Administration 510(k) clearance for its latest generation robotic system, GenesisX™.
— Polymer-based coil minimizes artifacts in imaging — BOULDER, Colo., Nov. 10, 2025 /PRNewswire/ — A woman in Delaware has become the first patient to undergo minimally invasive, endovascular surgery with a polymer-based coil. The coil, manufactured by Embolization, Inc., is a vascular…
The investigational device evaluated in the trial, previously known as the GORE® VIAFORT Vascular Stent, will now be referred to as the GORE® VIABAHN® FORTEGRA Venous Stent. CAUTION: Investigational device. Limited by United States law to investigational use. LAS VEGAS and FLAGSTAFF, Ariz….
The Velocity System is a next generation percutaneous AVF technology designed to reduce the need for reinterventions to achieve fistula maturation and improve hemodialysis vascular access outcomes while reducing costs. LOS GATOS, Calif., Nov. 6, 2025 /PRNewswire-PRWeb/ — Venova Medical,…
